STOCK TITAN

Syneos Health Names Jeanine O’Kane as Communications President

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

On April 4, 2023, Syneos Health (Nasdaq: SYNH) appointed Jeanine O’Kane as President of Syneos Health Communications, expanding her role from President of the US Public Relations Group. With over 20 years of industry experience and more than a decade at Syneos, O’Kane has been pivotal in creating award-winning communication strategies that integrate with clinical development. Chief Operating Officer Michael Brooks highlighted the importance of her leadership in driving growth and enterprise value amid fast-evolving scientific demands. Syneos Health Communications is recognized for impactful communication programs that enhance customer success globally.

Positive
  • Jeanine O’Kane's appointment could lead to enhanced leadership and innovative solutions in communications.
  • O’Kane's experience and prior success within the organization may strengthen Syneos Health's market position.
Negative
  • None.

MORRISVILLE, N.C., April 04, 2023 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced Jeanine O’Kane as President of Syneos Health Communications — a portfolio of agencies spanning advertising, public relations, patient advocacy, medical communications, managed markets, and naming and branding. Formally President of the US Public Relations Group at Syneos Health Communications, Jeanine has been with the organization for more than a decade and has more than 20 years of industry experience.

During her tenure at Syneos Health Communications, she has been instrumental in developing award-winning communications programs and has helped integrate communications and commercial expertise into clinical development – unlocking innovative solutions to deliver life-saving therapies to patients worldwide.

“Our Syneos Health Communications team plays a fundamental role in our integrated operating model – helping us better understand patient, provider and policy maker needs and behaviors, to develop strategies to enable our customers’ success,” said Michael Brooks, Chief Operating Officer, Syneos Health. “With science evolving at a record pace, we are excited for Jeanine to take on her new role as President, continuing to advance innovative solutions, to drive growth and enterprise value.”

“Every day, Syneos Health Communications operates at the Heart of Health – helping customers predict what’s next and respond to the market’s demand for smarter and faster answers,” said Jeanine O’Kane, President, Syneos Health Communications. “For more than a decade, I’ve witnessed the forward-thinking, impactful work this portfolio of agencies designs and delivers for our customers. I look forward to driving strong momentum in this new role and I’m excited for what’s next.”

Syneos Heath Communications is known for its award-winning, insights-based communications programs that resonate emotionally, nurture motivation and accelerate customer success. Award winning agencies include Addison Whitney, Biosector 2, BoldSky Creative Studio, Cadent, Chamberlain Healthcare Public Relations, Chandler Chicco Agency, GSW, Litmus, Genicos and Spherico.

About Syneos Health
Syneos Health® (Nasdaq: SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.  

We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. 

Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. 

Syneos Health supports a diverse, equitable and inclusive culture that cares for colleagues, customers, patients, communities and the environment.  

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast

Investor Relations Contact:Press/Media Contact:
Ronnie Speight Gary Gatyas
Senior Vice President, Investor Relations    Executive Director, External Communications
 +1 919 745 2745+1 908 763 3428
Investor.Relations@syneoshealth.comgary.gatyas@syneoshealth.com


FAQ

Who is the new President of Syneos Health Communications?

Jeanine O’Kane has been appointed as the new President of Syneos Health Communications.

What is the significance of Jeanine O’Kane's appointment at Syneos Health?

Her appointment is expected to drive growth and innovative solutions in Syneos Health Communications.

What experience does Jeanine O’Kane bring to her new role?

O’Kane has over 20 years of industry experience and has been with Syneos for more than a decade.

How does Syneos Health Communications contribute to the company's success?

It develops strategies that meet patient, provider, and policymaker needs, enhancing customer success.

What is Syneos Health known for?

Syneos Health is known for its integrated biopharmaceutical solutions that accelerate the delivery of important therapies.

Syneos Health, Inc.

NASDAQ:SYNH

SYNH Rankings

SYNH Latest News

SYNH Stock Data

4.46B
103.15M
0.49%
94.75%
6.52%
Diagnostics & Research
Healthcare
Link
United States
Morrisville